News
Fifteen of the biotechnology company’s products delivered at least double-digit sales growth in the second quarter.
Amgen Inc (NASDAQ:AMGN) shares held near flat in after-hours trading Tuesday despite posting better-than-expected quarterly ...
Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...
44m
Investor's Business Daily on MSNAmgen Beats Second-Quarter Expectations, So Why Are Sharing Diving?Amgen crushed second-quarter forecasts late Tuesday. But Amgen stock fell in late-afternoon trading following its report.
The Thousand Oaks, California-based company said it had net income of $2.65 per share. Earnings, adjusted for non-recurring costs, came to $6.02 per share. The results topped Wall Street expectations.
For the second quarter, total revenues increased 9% to $9.2 billion in comparison to the second quarter of 2024. Product sales grew 9%, driven by 13% volume g ...
This was the stock's second consecutive day of gains.
Amgen (NASDAQ:AMGN) is set to release its earnings on Tuesday, August 5, 2025. Historically, Amgen's stock has shown a ...
Amgen (AMGN) to announce Q2 earnings with expected 6% growth in EPS & revenue. Key acquisitions bolster rare disease pipeline ...
Amgen (AMGN) recently declared a $2.38 dividend per share, continuing its practice of rewarding shareholders, which aligns ...
Analysts estimate that Amgen will report an earnings per share (EPS) of $5.26. The announcement from Amgen is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results